TELESTA THERAPEUTICS INC T.TST

Value

[SamuelSamuelSam]

Folks,

I am relatively new to the board and this stock. Does this company only have one drug in the pipeline? 

Thanks

[1wascallywabbit]

Just one drug for them, and lots of drugs and alcohol for the shareholders. Lol

[IWillRetireSoon]

Excluding the drugs in the bodies of some posters.... MCNA is the key product. Other drugs have been developed and marketed in the past but no longer part of Telesta's focus. Interesting to note that while MCNA is designed to target specifically Bladder cancer, it would make sense that other types of cancer could possibly be treated too. However, no studies that I know of have investigated

[DamnYankees]

Expire,  I believe you to be correct in that there have been no advanced studies on other forms of cancer. I also believe you to be correct in suggeting that MCNA will more likely than not be effective on other cancers under the right trial protocol, Where I differ with you is the suggestion that the share price hinges on approval. There is no hinge. The share prices trades with somewhere

[IWillRetireSoon]

Share price is indeed well below where it should be. We have seen upticks for each of the bio conferences and for the publication in the journal. It also appears new investors are on board. All good signs. The big spike has yet to occur. I am not sure of events other than submission/approval or buyout/partnering that would spark the uptick... unless you are just referring to promotion. As for

[DamnYankees]

Expire, you need to review the chart. There have been no upticks on any of the IR or PR "efforts". and the Journal article had no effect either. There is no substance behind the supposed effort. If there were the volume would be 2 mil plus per day and the SP moving northward. I know that it is hard for prospective investors to sift through the multitude of FDA submission stage Bladder

[SamuelSamuelSam]

Thanks, Great Info, So when they submit in June, do you know what the time-table looks like from there?

[beechguy]

6 months if expedited review. 10 months otherwise. I believe the FDA within 60 days will say if they accept the submission as is or if changes need to be made to the submission. On rare occasions the FDA will approve drugs within the 6 month time frame. Won't hold my breathe on that one. The other drug we have is a water based formulation of MCNA called Oncocidin. It is a post chemo adjuvant

[DamnYankees]

Some Funds? Really? You think that TST will still be an independent operation with funds for other additional trial work. Here's hoping we are long sold by the time that rolls around. Not saying the chemo adjuvant isn't a nice idea but I don't think you want to be waiting around for that. At least not at the pace this crew moves.

[IWillRetireSoon]

Real value will be the intellectual property of that compound. Buyers/partners would include that as value but of course there would be a long timeline for development. I am sure the interested parties have been informed of it. Keep the current course of action and then start on the adjuvant ONCE we have buyout/partnership. But yeah, we are way undervalued at this point.